On the other hand, Chk2 is a serine/threonine kinase and functions as a barrier in tumorigenesis by maintaining genomic stability, and loss of Chk2 is known to be discovered in solid tumours, including ovarian cancer [9]. The gene discussed is CHEK2; the disease is ovarian cancer.